INTEGRATED PRODUCTION, PROCESSING AND DISTRIBUTION OF RADIOCHEMICALS & RADIOPHARMACEUTICALS
NTP Radioisotopes offers an integrated radiochemicals and radiopharmaceuticals service, from product to patient.
NTP offers a unique range of integrated products and services from its Pelindaba facilities. With an on-site nuclear reactor and cyclotron, dedicated radiochemicals processing complexes, our own radiopharmaceutical production plant, and a logistics team that specialises in round-the-clock, round-the-world transport and safe delivery of radioisotopes, we are literally able to help you with any stage of your radiation-based product requirements.
NTP’s on-site facilities include:
Irradiation services: Our reactor, SAFARI-1, is in operation more than 300 days a year and is one of the most highly commercially utilised research reactors in the world. In addition to the production of radioisotopes for medical applications, NTP also offers neutron transmutation doping of silicon crystals and other neutron irradiation services.
Radiochemicals production and processing: NTP is one of the leading global suppliers of molybdenum-99 and iodine-131. As of December 2015, more than 75% of our output is produced using low-enriched uranium (LEU). The SAFARI-1 reactor and our adjacent radiochemicals processing plant are both ISO 9001 and ISO 14001 compliant.
Radiopharmaceuticals processing: We have on-site processing facilities to supply radiopharmaceuticals either in kit form or as ready-to-use patient doses. Our products include the NovaTec-P Tc-99m generator; diagnostic-specific cold kits; cyclotron-based F-18 FDG (fluoro-2-deoxyglucose); iodine-131 therapy and diagnostic capsules; and lutetium-177 dotatate and PSMA. Our radiopharmaceutical facilities operate seven days a week, to ensure patients are able to receive life-saving doses as and when they are required.
Off-site facilities: NTP has partnered with the National Research Foundation’s iThemba LABS based near Cape Town. iThemba LABS operates a cyclotron facility in the Western Cape that provides the local market with accelerator-produced radioactive isotopes for nuclear medicine and research purposes.